Some studies have come up with a logic that vitamin D affects the β-cell function and insulin sensitivity which may be a potential pathogenic mechanism for the development of dyslipidemia in vitamin D deficiency, as the dyslipidemia is closely related to the insulin sensitivity [30]. The gene discussed is INS; the disease is metabolic syndrome.